Inherited Neuromuscular Diseases : Translation from Pathomechanisms to Therapies (Advances in Experimental Medicine and Biology) 〈Vol. 652〉

個数:

Inherited Neuromuscular Diseases : Translation from Pathomechanisms to Therapies (Advances in Experimental Medicine and Biology) 〈Vol. 652〉

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 304 p.
  • 言語 ENG
  • 商品コード 9789048128129
  • DDC分類 612

Full Description

This volume contains the text of the presentations delivered at the International Symposium on Rare Diseases "Inherited Neuromuscular Diseases: Translation from Pathomechanisms to Therapies", held in Valencia, Spain, from November 16 to 18, 2008. The symposium represents a part of the continuous efforts on dif- sion of science to the society of the Catedra Santiago Grisolia and the Fundacion Ciudad de las Artes y las Ciencias -Comunitat Valenciana. More than 200 inter- tional scientists from different countries of Europe, the USA, and Australia attended the meeting. The venue was the Auditorium of the Science Museum Principe Felipe. Ten years ago Alan Emery wrote in the preface of Neuromuscular Disorders: Clinical and Molecular Genetics the following comments: "It has been estimated that more than one person in every 3,000 has a serious disabling inherited n- romuscular disorder. The suffering caused by these disorders is considerable, but, until the last decade or so, virtually nothing was known of their pathogenesis. Any rationale approach to treatment was therefore out of the question. However, matters are now changing rapidly.
The genes for many of these disorders have been localised and characterised and their gene products identi ed and studied. The detection of preclinical disease, the identi cation of heterozygous carriers and prenatal di- nosis are all becoming possible, and, hopefully, effective treatments may no be too far distant.

Contents

Pathology and Diagnosis of Muscular Dystrophies.- Standards of Care for Duchenne Muscular Dystrophy: Brief Treat-NMD Recommendations.- Genetics and Pathogenesis of Distal Muscular Dystrophies.- Phenotype Variations in Early Onset Pompe Disease: Diagnosis and Treatment Results with Myozyme®.- Diseases of the Human Mitochondrial Oxidative Phosphorylation System.- Mitochondrial Diseases: A Cross-Talk Between Mitochondrial and Nuclear Genomes.- Mitochondrial Disorders Due to Nuclear OXPHOS Gene Defects.- Coenzyme Q10 Deficiencies in Neuromuscular Diseases.- The Role of Mitochondrial Network Dynamics in the Pathogenesis of Charcot-Marie-Tooth Disease.- Pathogenesis and Treatment of Mitochondrial Disorders.- Biology of Peripheral Inherited Neuropathies: Schwann Cell Axonal Interactions.- Phenotype and Clinical Evolution of Charcot-Marie-Tooth Disease Type 1A Duplication.- Genotypes & Sensory Phenotypes in 2 New X-Linked Neuropathies (CMTX3 and dSMAX) and Dominant CMT/HMN Overlap Syndromes.- Natural History and Treatment of Peripheral Inherited Neuropathies.- Spinal Muscular Atrophy During Human Development: Where Are the Early Pathogenic Findings?.- Spinal Muscular Atrophy.- Friedreich Ataxia: An Update on Animal Models, Frataxin Function and Therapies.- Genetics and Pathogenesis of Inherited Ataxias and Spastic Paraplegias.

最近チェックした商品